Press Releases for BAX

Press Releases
Baxter Raises Quarterly Dividend
Baxter Reports Double-Digit EPS Growth for Third Quarter 2009
Skin hydration product unveiled by Baxter
Baxter Named to Dow Jones Sustainability Index for 11th Consecutive Year
Laureate Pharma Elects New Board Member ; - Joel A. Tune Enhances Organization, Providing Leadership and Strategic Direction -
StockPreacher.com Issues Trading Outlook for Nabi Biopharmaceuticals
StockPreacher.Com Issues Trading Outlook for Keryx Biopharmaceuticals Inc.
Baxter Completes Production of First Commercial Batches of A/H1N1 Pandemic Vaccine
Baxter Declares Quarterly Dividend and Announces New Share Repurchase Authorization
Baxter Reports Strong Second Quarter 2009 Financial Results and Raises Full-Year Outlook
Baxter and Halozyme Announce Completion of Patient Enrollment in Phase III Pivotal Trial of GAMMAGARD LIQUID™ with rHuPH20 Enzyme
Baxter and Flamel Technologies Announce Collaboration to Formulate Longer Acting Forms of Blood Clotting Factors
Baxter International Second Quarter 2009 Financial Results Conference Call
Baxter International Second Quarter 2009 Financial Results Conference Call
Novavax Appoints Stanley Erck to Board of Directors
Baxter to Acquire Continuous Renal Replacement Therapy Business from Edwards Lifesciences
Edwards Lifesciences to Sell Its Hemofiltration Product Line to Baxter
Baxter Highlights Progress Toward Sustainability Priorities in 10th Annual Sustainability Report
Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections
Baxter to release flu vaccine in July
Baxter Advances to Full-Scale Production of A/H1N1 Vaccine
Baxter to Present at the William Blair Growth Stock Conference
AHRQ Director Carolyn Clancy, MD, Selected as 2009 Recipient of the William B. Graham Prize for Health Services Research
Michael A. DiPiano Appointed to CyberShift Board of Directors
U.S. probes heparin link in deaths
Baxter to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
Baxter’s Board of Directors Declares Quarterly Dividend
Baxter International Shareholders Meeting
Pharma Company Baxter International Bucks Trends With 20% Increase in 1Q09 Net Income, an Industrial Info News Alert
Baxter Announces Strong First Quarter Financial Results
Baxter Partners with World Federation of Hemophilia to Heighten Awareness of Vital Role of Comprehensive Care in Hemophilia Management and Global Disparities in Care
Baxter Enters into Exclusive Distribution Agreement with SIGMA International for Infusion Pumps
Baxter International First Quarter 2009 Financial Results Conference Call
Beacon Equity Issues Trade Alerts on Medical Device Stocks: ABT, BSX, JNJ, BAX, HSP, ZMH
Innocoll, Inc. Files 510 (k) Application for CollaRx Lidocaine Sponge
Baxter International First Quarter 2009 Financial Results Conference Call
Data Presented at AAAAI Reinforce Baxter’s Commitment to Making GAMMAGARD LIQUID Therapy More Convenient
Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients
Baxter to Present at the Cowen and Company 29th Annual Health Care Conference
FDA Classifies Recent Urgent Device Correction on Baxter’s COLLEAGUE Infusion Pump as a Class I Recall
Baxter and Its Foundation Contribute Nearly $44 Million in 2008 to Address Critical Needs Locally and Globally
Fitch Affirms Baxter International's IDR at 'A'; Outlook Stable
Baxter Reminds Those at Risk of Silent Killer to Get Screened and Know Treatment Options on World Kidney Day
Research and Markets: Asia Pacific Wound Care Management Investment Opportunities, Analysis and Forecasts to 2012
Baxter to Present at the Barclays Capital Global Healthcare Conference
Baxter Declares Quarterly Dividend
Zacks Analyst Blog Highlights: ABB Ltd., Baxter International, Inc., Abercrombie & Fitch, Cognizant Technology Solutions Holdings, Inc. And Satyam.
Zacks Bull & Bear of the Day Highlights: Baxter International, Marriott International, UDR, AIV and Vornado
Zacks Releases Four Powerful ''Buy'' Stocks: Activision Blizzard, Baxter International, UGI Corp. and Fuel Systems Solutions
Baxter Achieves Record Sales, Earnings and Cash Flow for Full-Year 2008
Baxter International Fourth Quarter 2008 Financial Results Conference Call - Jan 19 2009 5:00PM
St. Mary's Health System in Maine Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service
Baxter International Fourth Quarter 2008 Financial Results Conference Call - Jan 6 2009 5:37PM
Baxter to Present at the 27th Annual J.P. Morgan Healthcare Conference
BenchmarkJournal.Com (Complimentary) Analyst Review for BAX, KG, CVX and WHR
Baxter Receives EMEA Positive Opinion for CELVAPAN, The First Cell Culture-Based Pandemic Flu Vaccine
Research and Markets: Republic of Korea Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2012 - Out Now
Kenneth D. Lewis, Chairman, Chief Executive Officer and President of Bank of America, Addresses The Executives' Club of Chicago Global Leaders Luncheon.
Baxter Declares Quarterly Dividend, Increases Rate 20 Percent
AmeriCares Launches India Operations
Baxter to Present at the 2008 Annual Credit Suisse Health Care Conference
Chicago Public Schools Receive Major Corporate Donation for Science Education
Zacks Analyst Blog Highlights: Cemex S.A. De C.V., Baxter International Inc., Web.Com, Gilead Sciences, Inc. And Pfizer Inc.
Baxter Posts Strong Sales and Earnings for Third Quarter 2008
Seven Summits Research Releases Alerts on XOM, BIDU, MO, BAX, and MT
Baxter International Inc. Third Quarter 2008 Financial Results Conference Call
Growing Demand on Health Care Resources and Increased Incidence of Kidney Disease Draw Attention to Peritoneal Dialysis on Its 30th Anniversary
Baxter's Antimicrobial IV Technology Now Shown to Kill Six Common Pathogens, Including MRSA and VRE
Baxter Initiates Phase III Trial for the Treatment of Alzheimer's Disease
Baxter International Third Quarter 2008 Financial Results Conference Call
Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year
Baxter Announces Licensing Agreement for Innocoll's Gentamicin Surgical Implant in the United States
Baxter Declares Quarterly Dividend
Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results
Baxter International Second Quarter 2008 Financial Results Conference Call
Baxter International Second Quarter 2008 Financial Results Conference Call
Baxter Releases Ninth Annual Sustainability Report
The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine
Professor Sir Michael G. Marmot Selected as 2008 Recipient of the William B. Graham Prize for Health Services Research - Jun 1 2008 4:15AM
Baxter's Board of Directors Declares Quarterly Dividend - Jun 1 2008 4:15AM
Study Results of GAMMAGARD S/D and GAMMAGARD LIQUID in Patients with Mild-to-Moderate Alzheimer's Disease Announced
Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimer's Disease
Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals
Stock on the Move for Tuesday: ERUC! April 1, 2008
Aggressive Stock Alert: ERUC! April 1, 2008
SmallCap Sentinel: Sweet November, Historically Hot Market Month Lures Buyers
SmallCap Sentinel: Companies Target Breakthrough Technologies